#Global Trends – Page 18 – HEALTHCARE INSIGHTS

Key Development Global non-clinical research and biologics testing provider Charles River Laboratories International, Inc. (NYSE: CRL) and Taiwan-based vaccine developer... Read more

Tag: #Global Trends

European CDMO Infrastructure Expansion: SK pharmteco Completes Major Manufacturing Expansions in Swords, Ireland – Boosting Small-Molecule API, High-Potency API (HPAPI), and ADC Payload Capabilities

AI-Driven Biologics Engineering: Bristol Myers Squibb and Chai Discovery Partner to Accelerate De Novo Therapeutic Antibody Candidate Identification

Advanced Biologics Testing & CMC Validation: Charles River Laboratories and Medigen Partner to Validate Virus Seed Bank for Next-Generation Multivalent Enterovirus Vaccine

Mass Tort Litigation Defense: Abbott Agrees to $670 Million Settlement to Resolve 2,000 Preterm Infant Formula Necrotizing Enterocolitis (NEC) Claims

Mass Tort Litigation Defense: Abbott Agrees to $670 Million Settlement to Resolve 2,000 Preterm Infant Formula Necrotizing Enterocolitis (NEC) Claims

Breakthrough in Personalized Oncology: Moderna and Merck’s Tailored mRNA Cancer Vaccine Intismeran Cuts Melanoma Recurrence and Metastasis in Landmark Phase 3 Trial – Moderna Shares Surge 160%

CNS Patent Defense & Market Exclusivity: SK Biopharmaceuticals Reaches Landmark Patent Settlement with MSN Laboratories to Protect U.S. Exclusivity for Anti-Epileptic Blockbuster Xcopri® (Cenobamate) Beyond 2032

Ultrarare Genetic Disease Milestone: FDA Approves Regeneron’s Pasatru® (Garetosmab) for Fibrodysplasia Ossificans Progressiva (FOP) – Delivering Up to 94% Reduction in New Heterotopic Bone Lesions

AI-Augmented Surgical Robotics: Johnson & Johnson MedTech Secures FDA 510(k) Clearance for Monarch Quest 3 Software Enhancing Robotic Bronchoscopy and Lung Nodule Targeting

Facebook

Map

Online Members